DarioHealth Corp.
DRIO
$9.14
-$0.06-0.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.79% | 47.21% | 32.87% | -2.09% | -28.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.79% | 47.21% | 32.87% | -2.09% | -28.10% |
| Cost of Revenue | -3.80% | -8.05% | -12.39% | -13.81% | -30.29% |
| Gross Profit | 79.04% | 100.26% | 76.44% | 7.27% | -26.21% |
| SG&A Expenses | -18.03% | -7.53% | 10.30% | 19.45% | 16.28% |
| Depreciation & Amortization | -14.48% | 6.09% | 14.64% | 7.50% | 2.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.02% | -4.90% | 10.00% | 11.65% | 8.07% |
| Operating Income | 34.71% | 21.04% | -1.70% | -18.00% | -27.33% |
| Income Before Tax | 16.53% | 19.88% | 24.87% | 14.57% | 8.54% |
| Income Tax Expenses | 108.50% | 108.50% | -2,993.75% | -64,866.67% | -64,433.33% |
| Earnings from Continuing Operations | 13.04% | 16.69% | 28.07% | 17.93% | 11.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.04% | 16.69% | 28.07% | 17.93% | 11.89% |
| EBIT | 34.71% | 21.04% | -1.70% | -18.00% | -27.33% |
| EBITDA | 39.17% | 26.94% | 2.92% | -17.15% | -28.49% |
| EPS Basic | 42.20% | 64.62% | 66.22% | 53.94% | 45.72% |
| Normalized Basic EPS | 46.85% | 49.56% | 50.94% | 32.87% | 26.11% |
| EPS Diluted | 41.80% | 64.34% | 65.98% | 53.78% | 45.87% |
| Normalized Diluted EPS | 46.85% | 49.56% | 50.94% | 32.87% | 26.11% |
| Average Basic Shares Outstanding | 63.87% | 71.58% | 70.58% | 29.97% | 26.14% |
| Average Diluted Shares Outstanding | 63.87% | 71.58% | 70.58% | 29.97% | 26.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |